Aqueous Humor Cytokine Levels and Anatomic Response to Intravitreal Ranibizumab in Diabetic Macular Edema

医学 血管抑制剂 眼科 细胞因子 糖尿病性视网膜病变 血管内皮生长因子 内科学 糖尿病 贝伐单抗 内分泌学 血管内皮生长因子受体 化疗
作者
Roxane J. Hillier,Elvis Ojaimi,David T. Wong,Michael Y. K. Mak,Alan R. Berger,Radha P. Kohly,Peter J. Kertes,Farzin Forooghian,Shelley Boyd,Kenneth T. Eng,Filiberto Altomare,Louis R. Giavedoni,Rosane Nisenbaum,Rajeev H. Muni
出处
期刊:JAMA Ophthalmology [American Medical Association]
卷期号:136 (4): 382-382 被引量:59
标识
DOI:10.1001/jamaophthalmol.2018.0179
摘要

Variability in response to anti-vascular endothelial growth factor (VEGF) treatment in diabetic macular edema (DME) remains a significant clinical challenge. Biomarkers could help anticipate responses to anti-VEGF therapy.To investigate aqueous humor cytokine level changes in response to intravitreal ranibizumab therapy for the management of DME, and to determine the association between baseline aqueous levels and anatomic response.In this prospective multicenter cohort study, 49 participants with diabetes mellitus complicated by center-involving DME, with a central subfield thickness of 310 μm or greater on spectral-domain optical coherence tomography (SD-OCT), were recruited from December 22, 2011, to June 13, 2013 and statistical analysis were performed from March 1, 2017, to June 1, 2017. A total of 48 participants proceeded to follow-up.Participants received monthly injections of ranibizumab, 0.5 mg, for 3 months. Aqueous fluid for cytokine analysis was obtained at baseline and repeated at the 2-month visit. Multiplex immunoassay was carried out in duplicate for VEGF, placental growth factor, transforming growth factor beta 2, intercellular adhesion molecule 1 (ICAM-1), interleukin 6 (IL-6), IL-8, IL-10, vascular intercellular adhesion molecule, and monocyte chemoattractant protein 1.Baseline and 2-month change in aqueous cytokine levels, 3-month change in SD-OCT central subfield thickness and macular volume (MV), and the statistical association between baseline aqueous cytokine levels and these measures of anatomic response to ranibizumab in center-involving DME.Among the 48 participants, the mean (SD) age was 61.9 (7.1) years and 36 participants (75.0%) were men. The following cytokines were lower at month 2 vs baseline: ICAM-1 (median change, -190.88; interquartile range [IQR], -634.20 to -26.54; P < .001), VEGF (median change, -639.45; IQR, -1040.61 to -502.61; P < .001), placental growth factor (median change, -1.31; IQR, -5.99 to -0.01; P < .001), IL-6 (median change, -38.61; IQR, -166.72 to -2.80; P < .001), and monocyte chemoattractant protein 1 (median change, -90.13; IQR, -382.74 to 109.47; P = .01). When controlling for age, foveal avascular zone size, and severity of retinopathy, multiple linear regression determined that increasing baseline aqueous ICAM-1 was associated with a favorable anatomic response, in terms of reduced SD-OCT MV at 3 months (every additional 100 pg/mL of baseline ICAM-1 was associated with a reduction of 0.0379 mm3; P = .01). Conversely, increasing baseline aqueous VEGF was associated with a less favorable SD-OCT MV response at 3 months (every additional 100 pg/mL of baseline VEGF was associated with an increase of 0.0731 mm3; P = .02) and was associated with lower odds of being a central subfield thickness responder (odds ratio, 0.868; 95% CI, 0.755-0.998).Elevated aqueous ICAM-1 and reduced VEGF levels at baseline are associated with a favorable anatomic response to ranibizumab in DME, although there is not always direct correlation between anatomic and visual acuity response.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Jie152发布了新的文献求助10
刚刚
2秒前
2秒前
爆米花的应助被sssyt采纳,获得10
2秒前
3秒前
3秒前
AC完成签到,获得积分10
4秒前
4秒前
香蕉觅云的应助被lily采纳,获得10
5秒前
CipherSage的应助被幽默蓝天采纳,获得40
5秒前
科研通AI6.2的应助被koutianle采纳,获得10
6秒前
7秒前
爱吃芝士完成签到,获得积分10
7秒前
7秒前
7秒前
8秒前
快乐行云发布了新的文献求助10
8秒前
Auster发布了新的文献求助10
9秒前
杰儿发布了新的文献求助10
9秒前
9秒前
了了完成签到,获得积分10
9秒前
9秒前
xc完成签到 ,获得积分10
9秒前
英姑的应助被初初初啊采纳,获得10
10秒前
微语发布了新的文献求助30
10秒前
少言发布了新的文献求助10
11秒前
科研通AI2S的应助被眼睛大羽毛采纳,获得10
11秒前
充电宝的应助被Due_arrival采纳,获得10
12秒前
114514发布了新的文献求助10
12秒前
小立发布了新的文献求助10
13秒前
西柚七完成签到,获得积分10
14秒前
xiaolaiba发布了新的文献求助10
14秒前
15秒前
FFF完成签到,获得积分10
15秒前
晨许沫光完成签到 ,获得积分10
17秒前
17秒前
18秒前
yang完成签到 ,获得积分10
18秒前
烟花的应助被yuzu采纳,获得10
18秒前
没有名字完成签到,获得积分10
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
What Else Can I Tell You?: A Pragmatic Study of English Rhetorical Questions as Discursive and Argumentative Acts 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8165074
求助须知:如何正确求助?哪些是违规求助? 9558738
关于积分的说明 21747291
捐赠科研通 7755624
什么是DOI,文献DOI怎么找? 3428780
关于科研通互助平台的介绍 2553162
邀请新用户注册赠送积分活动 2473361